Discover 1,164 paid clinical trials in Cincinnati, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
With a focus on a variety of conditions such as lymphoma, cancer, neurological diseases, and sleep apnea, Cincinnati is home to a wide array of clinical studies. The city's leading medical centers are actively recruiting participants, offering paid research opportunities for healthy volunteers or trials for specific health conditions, providing access to innovative treatments and therapies.
Filter
2
Filter results
Results: 1,164
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
for
Chronic Kidney Disease and Hypertension
Location: Cincinnati OH, Indianapolis IN, Columbus OH, Canton OH,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06742723
Phase3, Recruiting
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
for
Heart Failure
Location: Cincinnati OH, Dayton OH, Beavercreek OH, Richmond IN,
Sponsor: AstraZeneca
Sex: All
Age: 40+
Code: NCT06677060
Phase3, Recruiting
Assessment of Retinal Fundus Imaging Camera
for
Diabetic Retinopathy, Diabetic Macular Edema
Location: Cincinnati OH
Sponsor: Digital Diagnostics, Inc.
Sex: All
Age: 22+
Code: NCT06173232
Recruiting
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
for
Schizophrenia, Bipolar I Disorder
Location: Cincinnati OH, West Chester OH, Indianapolis IN,
Sponsor: Alkermes, Inc.
Sex: All
Age: 10 - 17
Code: NCT05303064
Phase3, Recruiting
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
Location: Cincinnati OH, Liberty Township OH, Ypsilanti MI,
Sponsor: Mirador Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07113522
Phase2, Recruiting
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
for
Acute Myeloid Leukemia
Location: Cincinnati OH, Columbus OH, Chicago IL, Pittsburgh PA,
Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland
Sex: All
Age: 18+
Code: NCT07223814
Phase3, Recruiting
Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
for
Hidradenitis Suppurativa (HS)
Location: Cincinnati OH, Columbus OH, Bexley OH, Indianapolis IN,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06855498
Phase3, Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations